Teva Pharmaceuticals and Alvotech said on Friday they have launched a biosimilar to Johnson & Johnson's autoimmune drug Stelara in the United States, the second in a wave of near-copies of the ...
Teva Pharmaceutical (NYSE:TEVA) and Alvotech (NASDAQ:ALVO) have launched their biosimilar targeting Johnson & Johnson’s (NYSE ...
Discover the latest strategic moves of Duquesne Family Office's $3.72B portfolio, including new stakes, increased investments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results